Archive: Recommended Stocks & Mutual
Funds in the News
02/28/2004
--- Rockwell Collins
Chosen by Banc of America Securities as One of Two Top Firms
In Defense Sector.
Banc of America Securities has chosen Rockwell Collins and
General Dynamics as its two top aerospace and defense companies.
We recommended Rockwell Collins in October of 2001 and have
reaped the rewards of the stock's 123.6% gain. Over the same
time period, the S&P 500 rose only 7.1%.
01/26/2004
--- Jack Henry & Associates
Increases Common Dividend 14% to $.04 Per Share.
Jack Henry & Associates, up 34% since our buy signal nine
months ago (49% annualized), today announced that they will
increase their common dividend 14% to 4 cents per share. The
company processes ATM and debit card transactions for banks
and credit unions. It also provides integrated computer systems
for financial institutions.
12/21/03
--- Up 52.9% in the last 12
months, it has been a typical year for our recommended portfolio.
Our Primary Portfolio's value is up 472% since 1998 (35.6%
per year). Equal investments in the S&P 500 would have
resulted in a gain of only 1.3% per year. Meanwhile, our new
high-dividend blue chip portfolio has risen 31.0% in its first
eight months of existence (versus 16.1% for the market). The
portfolio is on pace to increase 54.1% in 12 months. We have
created a summary of our Primary Stock Portfolio's
performance here.
12/03/03
--- Two More Analysts Jump On The
GPRO Wagon After 165% Run Up in Price
In another example of too little, too late, two more Wall
Street analysts jumped on the Gen-Probe bandwagon (ticker:
GPRO), but only after the stock has risen 165.2% since we
recommended the company to our subscribers in January this
year. If you don't want to miss out on recommendations like
this, subscribe today.
10/31/03
--- Update on Zimmer.
Up 339% in three months.
Our more experienced subscribers have frequently requested
recommendations for options. As a result, we recommended buying
options for Zimmer Holdings on 7/31. The options have now
increased 339% in three months (an annualized rate of 1,356%).
Options are not suitable for most investors and as such, the
portfolio returns quoted on our web site do not include the
use of options. However, if we did include them, our returns
would be even higher.
9/19/03
--- Another 13% jump this week means
this stock is now up 174% this year.
Our recommended blood-screening technology company which recently
announced a 2-for-1 stock split, saw its stock price rise
13% this week and is now up 174% since we recommended it on
January 14, 2003. Six months after our recommendation, USB
Piper Jaffray initiated coverage on the company. They rated
the company as a "strong buy."
On June 18, a West Nile virus blood test
developed by the same company will be used in clinical trials
to test 80% of the U.S. blood supply. The company is a developer
of testing products used to screen donated blood and to diagnose
human disease.
On June 3, Merrill Lynch raised their price
target for the firm. The new price target ($45) was 18% above
the company's closing price for that date.
In addition, the company reached a major
milestone in May. They initiated a clinical trial of a product
that is designed to fully automate the nucleic acid testing
process.
9/12/03
--- Strong cash flow
results in 50% increase in dividend.
This furniture-and-fixtures company was up 7.2% this week
on news that strong cash flows have resulted in a 50% increase
in the dividend. The company has raised their dividend eleven
times since 1989. After being recommended for our High-Dividend
Blue Chip Stock Portfolio on 5/4/03, this company's stock
is up 38.7% (a pace of 149% per year).
9/3/03
--- Office equipment company,
up 97%, acquires competitor.
Additionally, on July 31, this company announced a 32% increase
in earnings per share and also authorized a $20 million increase
in its stock buyback program. The company's stock is up 97%
since we recommended it on March 3, 2002.
9/2/03
--- Takeover boosts shares. Stock
up 68%.
The medical equipment company we recommended to our subscribers
rose 9.1% during the last six trading days. Today the stockholders
of the takeover target (a rival) voted to approve the takeover
bid. The winning bid is thought to be at a bargain price.
The company is up 68% since being recommended.
Above are updates on some of our recommended
stocks and mutual funds. If you want to see exactly what stocks
and funds we recommend and when to buy and sell them, please
subscribe today. You'll
receive a complete listing of all of our recommended stocks,
mutual funds, and brokerage firms.
-Rex M. Jacobsen
Sr. Editor
|
